[go: up one dir, main page]

ES2097787T3 - Composicion farmaceutica para la administracion rectal de principios activos que presenta una accion de medicacion prevalentemente topica a nivel del colon. - Google Patents

Composicion farmaceutica para la administracion rectal de principios activos que presenta una accion de medicacion prevalentemente topica a nivel del colon.

Info

Publication number
ES2097787T3
ES2097787T3 ES91201485T ES91201485T ES2097787T3 ES 2097787 T3 ES2097787 T3 ES 2097787T3 ES 91201485 T ES91201485 T ES 91201485T ES 91201485 T ES91201485 T ES 91201485T ES 2097787 T3 ES2097787 T3 ES 2097787T3
Authority
ES
Spain
Prior art keywords
active principles
pharmaceutical composition
rectal administration
prevalently
principles presented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91201485T
Other languages
English (en)
Other versions
ES2097787T5 (es
Inventor
Giuliano Frigerio
Gabriele Brunetti
Enzo Giorgetti
Emilia Chiodini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Giuliani SpA
Original Assignee
Giuliani SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11176813&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2097787(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Giuliani SpA filed Critical Giuliani SpA
Application granted granted Critical
Publication of ES2097787T3 publication Critical patent/ES2097787T3/es
Publication of ES2097787T5 publication Critical patent/ES2097787T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

ESTA INVENCION DESCRIBE UNA COMPOSICION FARMACEUTICA PARA LA ADMINISTRACION VIA RECTAL DE PRINCIPIOS ACTIVOS QUE EXHIBEN UNA ACCION DE MEDICACION TOPICA PREDOMINANTE A NIVEL DEL COLON, CARACTERIZADA EN QUE DICHOS PRINCIPIOS ACTIVOS ESTAN FORMULADOS EN UN VEHICULO FLUIDO CAPAZ DE GENERAR UNA ESPUMA EN LA ADMINISTRACION RECTAL.
ES91201485T 1990-07-27 1991-06-14 Composicion farmaceutica para la administracion rectal de principios activos que presenta una accion de medicacion prevalentemente topica a nivel del colon. Expired - Lifetime ES2097787T5 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT02110490A IT1243379B (it) 1990-07-27 1990-07-27 Composizione farmaceutica adatta alla somministrazione rettale di principi attivi che esplicano un'azione di medicazione a livello del colon prevalentemente di tipo topico

Publications (2)

Publication Number Publication Date
ES2097787T3 true ES2097787T3 (es) 1997-04-16
ES2097787T5 ES2097787T5 (es) 2001-04-01

Family

ID=11176813

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91201485T Expired - Lifetime ES2097787T5 (es) 1990-07-27 1991-06-14 Composicion farmaceutica para la administracion rectal de principios activos que presenta una accion de medicacion prevalentemente topica a nivel del colon.

Country Status (10)

Country Link
US (1) US5449520A (es)
EP (1) EP0468555B2 (es)
JP (1) JP3291301B2 (es)
AT (1) ATE146674T1 (es)
CA (1) CA2044676C (es)
DE (1) DE69123795T3 (es)
DK (1) DK0468555T4 (es)
ES (1) ES2097787T5 (es)
GR (2) GR3022790T3 (es)
IT (1) IT1243379B (es)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9414699D0 (en) * 1994-07-21 1994-09-07 Slagel David Aqueous foamable composition
DE4446891A1 (de) * 1994-12-27 1996-07-04 Falk Pharma Gmbh Stabile wäßrige Budesonid-Lösung
US5968906A (en) * 1995-02-02 1999-10-19 Chugai Seiyaku Kabushiki Kaisha Sucralfate preparations
MX9800125A (es) 1995-06-27 1998-03-31 Boehringer Ingelheim Kg Nuevas composiciones medicinales estables para generar aerosoles libres de gas propulsor.
IT1277663B1 (it) * 1995-09-28 1997-11-11 Crinos Industria Farmaco Sospensioni acquose stabili di mesalazina per uso topico
US7135191B2 (en) * 1997-09-04 2006-11-14 Zsolt Istvan Hertelendy Urogenital or anorectal transmucosal vaccine delivery system
US6239120B1 (en) 1998-03-17 2001-05-29 Pharmalink Ab Method and means for treating glomerulonephritis
US6326364B1 (en) * 1999-02-08 2001-12-04 Cedars-Sinai Medical Center Use of 5-aminosalicylates as antimicrobial agents
DE19941933A1 (de) * 1999-09-03 2001-03-15 Cognis Deutschland Gmbh Tensidsysteme
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
EP1312368A1 (de) * 2001-11-19 2003-05-21 Dr. Falk Pharma Gmbh Zusammensetzungen enthaltend Mesalazin zur Behandlung von entzündlichen Darmerkrankungen
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9668972B2 (en) * 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
JP2006505583A (ja) 2002-10-25 2006-02-16 フォーミックス エルティーディー． 化粧剤および医薬用フォーム
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
JP2005015365A (ja) * 2003-06-25 2005-01-20 Koike Kagaku Kk エアゾール型洗浄消毒剤
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
AU2007207116B2 (en) * 2006-01-19 2012-08-02 Disphar International B.V. Foam-forming composition
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US7645801B2 (en) 2007-01-29 2010-01-12 Alaven Pharmaceutical Llc Reduced irritant enema for treatment of inflammatory bowel disease (IBD)
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
AU2009205314A1 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US8945516B2 (en) 2009-10-02 2015-02-03 Foamix Pharmaceuticals Ltd. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US20130202654A1 (en) 2009-11-23 2013-08-08 Cipla Limited Topical Foam Composition
CA2781580A1 (en) 2009-11-23 2011-05-26 Cipla Limited Topical foam composition
US8174881B2 (en) 2009-11-24 2012-05-08 Micron Technology, Inc. Techniques for reducing disturbance in a semiconductor device
PT3115037T (pt) 2015-07-08 2018-10-22 Dr Falk Pharma Gmbh Formulação farmacêutica para o tratamento de alterações inflamatórias do reto
MX377365B (es) 2016-09-08 2025-03-10 Journey Medical Corp Composiciones y métodos para tratar rosácea y acné.
KR20190110092A (ko) * 2016-12-16 2019-09-27 훼링 비.브이. 직장 포움 제형

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0015334B1 (en) * 1977-08-04 1982-05-19 J.B. Tillott Limited Carminative preparations containing peppermint oil or its active components
JPS5921613A (ja) * 1982-07-28 1984-02-03 Takeda Chem Ind Ltd 直腸投与製剤
US4664256A (en) * 1983-09-06 1987-05-12 Farmaceutisk Laboratorium Ferring A/S Packaged stable enema solution or suspension containing 5-aminosalicyclic acid
US4609403A (en) * 1984-03-12 1986-09-02 Warner-Lambert Company Foam soft gelatin capsules and their method of manufacture
US4814183A (en) * 1987-08-31 1989-03-21 Merck & Co., Inc. Device for the controlled release of drugs with Donnan-like modulation by charged insoluble resins
US5206268A (en) * 1988-08-16 1993-04-27 Burroughs Wellcome Co. Medicaments
GB8909559D0 (en) * 1989-04-26 1989-06-14 Smith Kline French Lab Pharmaceutical compositions
FR2647344B1 (fr) * 1989-05-25 1995-06-02 Physiopharm Sarl Mousse aerosol a usage rectal

Also Published As

Publication number Publication date
EP0468555B2 (en) 2001-02-07
US5449520A (en) 1995-09-12
DE69123795T3 (de) 2001-07-12
EP0468555A1 (en) 1992-01-29
JPH04234315A (ja) 1992-08-24
JP3291301B2 (ja) 2002-06-10
DE69123795D1 (de) 1997-02-06
ES2097787T5 (es) 2001-04-01
EP0468555B1 (en) 1996-12-27
IT1243379B (it) 1994-06-10
GR3035634T3 (en) 2001-06-29
DK0468555T4 (da) 2001-04-02
GR3022790T3 (en) 1997-06-30
ATE146674T1 (de) 1997-01-15
IT9021104A0 (it) 1990-07-27
DK0468555T3 (da) 1997-06-09
CA2044676A1 (en) 1992-01-28
CA2044676C (en) 2003-04-01
DE69123795T2 (de) 1997-07-10
IT9021104A1 (it) 1992-01-27

Similar Documents

Publication Publication Date Title
ES2097787T3 (es) Composicion farmaceutica para la administracion rectal de principios activos que presenta una accion de medicacion prevalentemente topica a nivel del colon.
ES2180735T3 (es) Liquidos enmascaradores del sabor.
PE20020307A1 (es) Forma de dosificacion de farmaco activada por hidrogel
DE60005819D1 (de) Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe
ATE289214T1 (de) Dünner polymerfilm als medikamentenreservoir
GT200000222A (es) Forma de dosificacion de farmacos accionada por un hidrogel.
DZ1966A1 (fr) Combinaison pharmaceutique nouvelle.
MXPA02007915A (es) Mediador de lipido activado por aspirina.
SE0003449D0 (sv) Anticancer compositions
DE60006376D1 (de) Nikotinhaltige verabreichungssysteme
ATE64091T1 (de) Tablette mit verzoegerter freisetzung.
AR034691A1 (es) Composiciones farmaceuticas de administracion oral, que contiene un inhibidor de lipasa gastrointestinal, el comprimido masticable y la galleta que los comprende
CL2008003941A1 (es) Uso de escitalopram o de una sal farmaceuticamente aceptable del mismo para preparar un medicamento util en el tratamiento del desorden compulsivo obsesivo.
DE69113195D1 (de) Fluidpumpe für Doppelfördermenge.
NO20011217D0 (no) Doseringsform omfattende væskeformulering
AR034142A1 (es) Una composicion farmaceutica, metodo para fabricar un medicamento en base a dicha composicion y uso de la composicion
HRP20080597T3 (en) Cancer combination therapy comprising azd2171 and zd1839
NO20031650D0 (no) Nye legemidler for leversykdommer
ES2175153T3 (es) Uso de inhibidores de colinesterasa para la fabricacion de un medicamento para el tratamiento de la xerostomia.
ES2165970T3 (es) Forma farmaceutica solida con principio activo distribuido en un material polimerico.
DE59510583D1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
AR033862A1 (es) Formulacion de medicamento que contiene un agente agonista muscarinico
ATE259229T1 (de) Medikament sowie aufeinander abgestimmte kombination von medikamenten
DE69904020D1 (de) Pharmazeutische zusammensetzung zur nasalen verabreichung von thiocolchicosid
RU96115480A (ru) Лекарственное средство, обладающее холелитолитическим действием

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 468555

Country of ref document: ES